Brief: Liminal Biosciences Announces Listing Transfer To Nasdaq Capital Market
01/09/2022 21:54
Sept 1 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES ANNOUNCES LISTING TRANSFER TO NASDAQ
CAPITAL
MARKET
* LIMINAL BIOSCIENCES INC - COMMON SHARES WILL BEGIN TRADING
ON
NASDAQ CAPITAL MARKET EFFECTIVE AT START OF TRADING ON SEPTEMBER
6, 2022
Source text for Eikon: ID:nCNWHlnX9a
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy